Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goepel

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Der Urologe. Ausg. A|February 23, 2013
[Documentation of the Governing Body of Prostate Centers (DVPZ)]B Brehmer, R Berges, T Ebert, et al.
Der Urologe. Ausg. A|June 26, 2007
[Spontaneous renal angiomyolipoma rupture. Rare differential diagnosis of renal ruptures]S Kosciesza, C Möhring, J Kirchner, et al.
Der Urologe. Ausg. A|March 19, 1999
[Detrusor myectomy (autoaugmentation) in the treatment of hyper-reflexive low compliance bladder]M Stöhrer, M Goepel, G Kramer, et al.
Urological Research|January 1, 1993
E-cadherin: a marker for differentiation and invasiveness in prostatic carcinomaT Otto, K Rembrink, M Goepel, et al.
Der Urologe. Ausg. A|July 1, 1996
[Are their individual decisions for urinary diversion? Indications and results of 200 consecutive patients]S Krege, M Goepel, M Meyer-Schwickerath, et al.
The Prostate|March 6, 1999
Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitroM Goepel, U Hecker, S Krege, et al.
Investigative Urology (Berlin, Germany)|January 1, 1994
E-cadherin: expression of the epithelial cell-cell-adhesion molecule in prostatic carcinoma and normal prostateK Rembrink, T Otto, M Goepel, et al.
Der Urologe. Ausg. A|January 29, 2013
[Urodynamic testing of the lower urinary tract]A Reitz, C Seif, R Kirschner-Hermanns, et al.
The Journal of Urology|May 8, 2000
Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasiaM C Michel, L Mehlburger, H Schumacher, et al.
The Journal of Urology|February 1, 1996
Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinomaG Lümmen, M Goepel, S Möllhoff, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Der Urologe. Ausg. A|February 23, 2013
[Documentation of the Governing Body of Prostate Centers (DVPZ)]B Brehmer, R Berges, T Ebert, et al.
Der Urologe. Ausg. A|June 26, 2007
[Spontaneous renal angiomyolipoma rupture. Rare differential diagnosis of renal ruptures]S Kosciesza, C Möhring, J Kirchner, et al.
Der Urologe. Ausg. A|March 19, 1999
[Detrusor myectomy (autoaugmentation) in the treatment of hyper-reflexive low compliance bladder]M Stöhrer, M Goepel, G Kramer, et al.
Urological Research|January 1, 1993
E-cadherin: a marker for differentiation and invasiveness in prostatic carcinomaT Otto, K Rembrink, M Goepel, et al.
Der Urologe. Ausg. A|July 1, 1996
[Are their individual decisions for urinary diversion? Indications and results of 200 consecutive patients]S Krege, M Goepel, M Meyer-Schwickerath, et al.
The Prostate|March 6, 1999
Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitroM Goepel, U Hecker, S Krege, et al.
Investigative Urology (Berlin, Germany)|January 1, 1994
E-cadherin: expression of the epithelial cell-cell-adhesion molecule in prostatic carcinoma and normal prostateK Rembrink, T Otto, M Goepel, et al.
Der Urologe. Ausg. A|January 29, 2013
[Urodynamic testing of the lower urinary tract]A Reitz, C Seif, R Kirschner-Hermanns, et al.
The Journal of Urology|May 8, 2000
Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasiaM C Michel, L Mehlburger, H Schumacher, et al.
The Journal of Urology|February 1, 1996
Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinomaG Lümmen, M Goepel, S Möllhoff, et al.
Pageof 11